We’ve updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

What Are the Key Projections for the CAGR of the Complete Blood Count Device Market Size From 2025 to 2034?

There has been significant growth in the complete blood count device market in recent years. The market, standing at $4.11 billion in 2024, is expected to rise to $4.36 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.2%. Factors such as the increasing occurrences of infectious diseases, heightened preventive healthcare awareness, larger diagnostic laboratory networks, growth in public health screening programs, and an uptick in the senior population have contributed to this historic growth.

The market for complete blood count devices is projected to experience robust expansion in the coming years, ballooning to an estimated worth of $5.51 billion by 2029, with a compound annual growth rate (CAGR) of 6.0%. This surge in growth during the forecasted period can be linked to progressive advancements in hematology analyzers, the fusion of AI and automation in diagnostic procedures, increasing preference for point-of-care testing, enhanced healthcare spending in budding markets, and the escalating occurrence of chronic ailments. The major tendencies anticipated during this period involve the utilization of AI for results interpretation, the application of miniaturization in point-of-care testing, the ability to transmit data wirelessly, the progression of cartridge-based consumables, and the inclusion of multiplex testing features.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24195&type=smp

What Are the Core Market Drivers Propelling Growth in the Complete Blood Count Device Industry?

The rise in incidents of blood disorders is forecasted to boost the advancement of the complete blood count device market in the future. Blood disorders refer to conditions that interfere with the generation, function, or formation of blood cells, which lead to compromised blood activity. This increase in blood disorders is linked to the escalating prevalence of lifestyle diseases, which are often caused by poor nutrition, a sedentary lifestyle, and stress, leading to conditions such as anemia and clotting problems. A complete blood count (CBC) device plays a critical role in diagnosing blood disorders. It examines key blood components and detects any irregularities, which enables healthcare professionals to identify coagulation disorders and ensure timely and accurate treatment. For example, the Canadian Cancer Society, a Canada-based institution, reported in May 2024 that 4,100 individuals were diagnosed with multiple myeloma, a form of blood cancer, and 1,750 people lost their lives to the disease. Hence, the rising prevalence of blood disorders is steering the expansion of the complete blood count device market.

How Is the Complete Blood Count Device Market Segmented?

The complete blood count device market covered in this report is segmented –

1) By Device Type: Automated Blood Count Analyzers, Manual Blood Count Analyzers, Point-Of-Care Testing Devices, Hematology Analyzers

2) By Test Type: White Blood Cell Count (WBC Or Leukocyte Count), White Blood Cell (WBC) Differential Count, Red Blood Cell Count (RBC Or Erythrocyte Count), Hematocrit (Hct), Hemoglobin (Hbg), Platelet Count, Mean Platelet Volume (MPV), Mean Corpuscular Hemoglobin (MCH), Other Test Types

3) By Technology: Impedance Technology, Laser-Based Technology, Flow Cytometry, Microscopy

4) By Distribution Channel: Direct Sales, Online Sales, Third-Party Distributors, Retail Pharmacies

5) By End-User: Hospital, Diagnostic Laboratories, Research Institutes, Other End-Users

Subsegments:

1) By Automated Blood Count Analyzers: 3-Part Differential Analyzers, 5-Part Differential Analyzers, 6-Part And Above Differential Analyzers, Integrated Hematology Systems, High-Throughput Lab Analyzers

2) By Manual Blood Count Analyzers: Hemocytometers, Microscopes For Manual Differential, Manual Cell Counters, Staining Kits And Reagents

3) By Point-of-Care Testing Devices: Portable Hematology Analyzers, Handheld Complete Blood Count (CBC) Devices, Fingerstick Blood Test Devices, Rapid Diagnostic Complete Blood Count (CBC) Kits

4) By Hematology Analyzers: Low-Volume Hematology Analyzers, Mid-Volume Hematology Analyzers, High-Volume Hematology Analyzers, Veterinary Hematology Analyzers, Reagent-Free Analyzers

Request customized data on this market:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24195&type=smp

Which Regions Are Driving the Next Phase of the Complete Blood Count Device Market Growth?

North America was the largest region in the complete blood count device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the complete blood count device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Market Trends and Innovations Are Shaping the Future of the Complete Blood Count Device Industry?

Key corporations in the complete blood count device market are emphasizing on introducing more advanced products like compact hematology analyzers. These devices offer fast, precise and cost-effective solutions for point-of-care tests. They bring convenience to the table, being portable, easy to navigate, and providing quick and precise results for a complete blood count (CBC) with only a minor sample volume requirement. This makes them perfectly suited for on-the-spot usage, improving diagnostic precision, efficiency, and ease while being cost-effective and effortless to maintain. HORIBA, an analytical and measurement technology firm based in Japan, for example, unveiled the Yumizen H550E and H500E hematology analyzers in June 2024. The devices are compact and combine erythrocyte sedimentation rate (ESR) tests with complete blood count (CBC) and 5-part differential (DIFF) analysis. Leveraging HORIBA’s unique CoRA (correlated rouleaux analysis) technology, they can deliver comprehensive results from complete blood samples in merely a minute.

View the full report here:

https://www.thebusinessresearchcompany.com/report/complete-blood-count-device-global-market-report

How Is the Complete Blood Count Device Market Defined and What Are Its Core Parameters?

A complete blood count (CBC) device is a medical instrument used to perform a complete blood count, a standard laboratory test that measures the levels and characteristics of various blood components. It automates the blood analysis process, delivering precise and rapid results, which assist healthcare professionals in making well-informed decisions for diagnosis and treatment.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/customise?id=24195&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model